Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence

Yuan, 2014, Stereotactic body radiation therapy using the CyberKnife system for patients with liver metastases, Onco Targets Ther, 7, 915, 10.2147/OTT.S58409 Bengmark, 1969, The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy, Cancer, 23, 198, 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO;2-J Mohammad, 2009, Surgical management of colorectal liver metastases, Clin Colon Rectal Surg, 1, 225, 10.1055/s-0029-1242462 Choti, 2002, Trends in long-term survival following liver resection for hepatic colorectal metastases, Ann Surg, 235, 759, 10.1097/00000658-200206000-00002 Wagner, 1984, The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment, Ann Surg, 199, 502, 10.1097/00000658-198405000-00002 Akgül, 2014, Role of surgery in colorectal cancer liver metastases, World J Gastroenterol, 20, 6113, 10.3748/wjg.v20.i20.6113 Van Cutsem, 2010, Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment, Ann Oncol, 21, v93, 10.1093/annonc/mdq222 Corbin, 2013, Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy, J Clin Oncol, 31, 1384, 10.1200/JCO.2012.45.9651 Goodman, 2015, Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases, Pract Radiat Oncol, 6, 86, 10.1016/j.prro.2015.10.011 Lemke, 2016, Survival and prognostic factors of colorectal liver metastases after surgical and nonsurgical treatment, Clin Colorectal Cancer, 15, e183, 10.1016/j.clcc.2016.04.007 Stintzing, 2010, Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients, Eur J Cancer, 46, 1026, 10.1016/j.ejca.2010.01.008 Kennedy, 2016, Safety and efficacy of radioembolization in elderly (≥ 70 years) and younger patients with unresectable liver-dominant colorectal cancer, Clin Colorectal Cancer, 15, 141, 10.1016/j.clcc.2015.09.001 Yoon, 1999, Surgical treatment and other regional treatments for colorectal cancer liver metastases, Oncologist, 4, 197, 10.1634/theoncologist.4-3-197 Stintzing, 2013, Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases, Acta Oncol, 52, 971, 10.3109/0284186X.2013.766362 Ravikumar, 1996, Interstitial therapies for liver tumors, Surg Oncol Clin N Am, 5, 365, 10.1016/S1055-3207(18)30387-9 Solbiati, 2001, Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients, Radiology, 221, 159, 10.1148/radiol.2211001624 Oshowo, 2003, Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases, Br J Surg, 90, 1240, 10.1002/bjs.4264 Dawson, 2011, Overview: where does radiation therapy fit in the spectrum of liver cancer local-regional therapies?, Semin Radiat Oncol, 21, 241, 10.1016/j.semradonc.2011.05.009 Fiorentini, 2012, Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study, Anticancer Res, 32, 1387 Schefter, 2011, Radiation therapy for liver metastases, Semin Radiat Oncol, 21, 264, 10.1016/j.semradonc.2011.05.006 Wulf, 2004, Stereotactic boost irradiation for targets in the abdomen and pelvis, Radiother Oncol, 70, 31, 10.1016/j.radonc.2003.10.013 Høyer, 2012, Radiotherapy for liver metastases: a review of evidence, Int J Radiat Oncol Biol Phys, 82, 1047, 10.1016/j.ijrobp.2011.07.020 Kim, 2016, Cost effectiveness analysis of stereotactic body radiation therapy compared with radiofrequency ablation for inoperable colorectal liver metastases, Int J Radiat Oncol, 95, 1175, 10.1016/j.ijrobp.2016.02.045 Tree, 2013, Stereotactic body radiotherapy for oligometastases, Lancet Oncol, 14, e28, 10.1016/S1470-2045(12)70510-7 Salama, 2014, Radical irradiation of extracranial oligometastases, J Clin Oncol, 32, 2902, 10.1200/JCO.2014.55.9567 Rusthoven, 2009, Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases, J Clin Oncol, 27, 1572, 10.1200/JCO.2008.19.6329 Boda-Heggemann, 2012, Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases–clinical results, Radiat Oncol, 7, 92, 10.1186/1748-717X-7-92 Niibe, 2010, Oligometastases and oligo-recurrence: the new era of cancer therapy, Jpn J Clin Oncol, 40, 107, 10.1093/jjco/hyp167 Timmerman, 2008, An overview of hypofractionation and introduction to this issue of seminars in radiation oncology, Semin Radiat Oncol, 18, 215, 10.1016/j.semradonc.2008.04.001 Eisenhauer, 2009, New Response Evaluation Criteria In Solid Tumours: revised RECIST guideline (version 1.1), Eur J Cancer, 45, 228, 10.1016/j.ejca.2008.10.026 US Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) version 4.0. Bethesda, MD: National Cancer Institute. 2009 (09-5410). McKinney, 2010, Data structures for statistical computing in python, Vol. 445, 51 Ahmed, 2016, Radiosensitivity differences between metastases based on primary histology suggest implications for clinical outcomes follwoing SBRT, Int J Radiat Oncol Biol Phys, 95, 1399, 10.1016/j.ijrobp.2016.03.050 Chang, 2011, Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis, Cancer, 117, 4060, 10.1002/cncr.25997 Takeda, 2016, Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-Adapted dose prescription with a maximum dose of 83-100 Gy in five fractions, J Radiat Res, 57, 400, 10.1093/jrr/rrw029 Stintzing, 2010, Radiosurgery of liver tumors: value of robotic radiosurgical device to treat liver tumors, Ann Surg Oncol, 17, 2877, 10.1245/s10434-010-1187-9 Sanabria, 2010, Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results, HPB Surg, 2010, 309780 Swaminath, 2015, Accumulated delivered dose response of stereotactic body radiation therapy for liver metastases, Int J Radiat Oncol Biol Phys, 93, 639, 10.1016/j.ijrobp.2015.07.2273 Méndez Romero, 2006, Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study, Acta Oncol, 45, 831, 10.1080/02841860600897934